CHEN Ya-Juan, WANG Lei, ZHOU Guang-Yu, YU Xian-Lun, ZHANG Yong-Hui, HU Na, LI Qing-Qing, CHEN Chen, QING Chen, LIU Ying-Ting, YANG Wei-Min. Scutellarin attenuates endothelium-dependent aasodilation impairment induced by hypoxia reoxygenation, through regulating the PKG signaling pathway in rat coronary artery[J]. Chinese Journal of Natural Medicines, 2015, 13(4): 264-273.
Citation: CHEN Ya-Juan, WANG Lei, ZHOU Guang-Yu, YU Xian-Lun, ZHANG Yong-Hui, HU Na, LI Qing-Qing, CHEN Chen, QING Chen, LIU Ying-Ting, YANG Wei-Min. Scutellarin attenuates endothelium-dependent aasodilation impairment induced by hypoxia reoxygenation, through regulating the PKG signaling pathway in rat coronary artery[J]. Chinese Journal of Natural Medicines, 2015, 13(4): 264-273.

Scutellarin attenuates endothelium-dependent aasodilation impairment induced by hypoxia reoxygenation, through regulating the PKG signaling pathway in rat coronary artery

  • Scutellarin (SCU), a flavonoid from a traditional Chinese medicinal plant. Our previous study has demonstrated that SCU relaxes mouse aortic arteries mainly in an endothelium-depend-ent manner. In the present study, we investigated the vasoprotective effects of SCU against HR-induced endothelial dysfunction (ED) in isolated rat CA and the possible mechanisms involving cyclic guanosine monophosphate (cGMP) dependent protein kinase (PKG). The isolated endothelium-intact and endothelium-denuded rat CA rings were treated with HR injury. Evaluation of endothelium-dependent and-independent vasodilation relaxation of the CA rings were performed using wire myography and the protein expressions were assayed by Western blotting. SCU (10-1 000 molL-1) could relax the endothelium-intact CA rings but not endothelium-denuded ones. In the intact CA rings, the PKG inhibitor, Rp-8-Br-cGMPS (PKGI-rp, 4 molL-1), significantly blocked SCU (10-1 000 molL-1)-induced relaxation. The NO synthase (NOS) inhibitor, NO-nitro-L-arginine methylester (L-NAME, 100 molL-1), did not significantly change the effects of SCU (10-1 000 molL-1). HR treatment significantly impaired ACh-induced relaxation, which was reversed by pre-incubation with SCU (500 molL-1), while HR treatment did not altered NTG-induced vasodilation. PKGI-rp (4 molL-1) blocked the protective effects of SCU in HR-treated CA rings. Additionally, HR treatment reduced phosphorylated vasodilator-stimulated phosphoprotein (p-VASP,phosphorylated product of PKG), which was reversed by SCU pre-incubation, suggesting that SCU activated PKG phosphorylation against HR injury. SCU induces CA vasodilation in an endothelium-dependent manner to and repairs HR-induced impairment via activation of PKG signaling pathway.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return